국소성 분절성 사구체 신병증의 동물 모델 (FGS/kist 생쥐) 신 조직의 유전자 발현 양상
Transcriptome Profiling of Kidney Tissue from FGS/kist Mice, the Korean Animal Model of Focal Segmental Glomerulosclerosis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목 적:국소성 분절성 사구체 경화증(Focal segmental glomerulosclerosis, 이하 FSGS)은 소아 신부전의 원인 중 가장 흔한 사구체 질환이다. 일차성 FSGS의 병인은 아직 알려져 있지 않으므로, 저자들은 FSGS의 동물 모델을 대상으로 cDNA 마이크로어레이를 이용한 유전자 발현 양상 분석을 통하여 유전자 발현 수준에서의 FSGS의 질환의 특성을 밝히고자 하였다. 방 법:사람의 일차성 FSGS와 유사한 질병경과를 보이는 동물모델인 FGS/kist 생쥐의 신피질 조직을 대조군 생쥐(FGS/kist 생쥐의 조상 strain인 RFM/kist 생쥐)와 AB 1700 mouse chip을 이용한 마이크로어레이 실험으로 비교하였다. 결 과:FGS 질병특이 유전자가 62개 추출되었다. 이들은 세포주기/사멸, 면역반응과 지질 대사/혈관 질환과 관련된 유전자들로써, 유전자간 network의 중심유전자가 면역반응(TNF, IL-6/4, IFNg)과 세포사멸 조절 유전자(TP 53), 그리고 지질대사의 중요 유전자인 PPARG이었다. 결론:이 연구에서 저자들은 자발적인 FSGS의 임상경과를 보이는 FGS/Kist 생쥐의 신장조직의 유전자 발현의 분석을 통하여 신장세포사멸과 면역반응에 뒤따르는 기질 섬유화, 그리고 지질 대사의 이상과 조기 혈관 질환이 FSGS의 병태생리에 기여할 것임을 다시 확인할 수 있었다. 추가적인 연구가 계속된다면 global transcriptome profiling 기법으로 병인 탐색 및 치료방법 개발 에 의미 있는 결과를 도출할 수 있을 것이다.
Abstract
Purpose:Focal segmental glomerulosclerosis (FSGS) is the most common glomerulopathy causing pediatric renal failure. Since specific treatment targeting the etiology and pathophysiology of primary FSGS is yet elusive, the authors explored the pathophysiology of FSGS by transcriptome analysis of the disease using an animal model. Methods:FGS/kist strain, a mouse model of primary FSGS, and RFM/kist strain, as control and the parent strain of FGS/kist, were used. Kidney tissues were harvested and isolated renal cortex was used to extract mRNA, which was run on AB 1700 mouse microarray chip after reverse transcription to get the transcriptome profile. Results:Sixty two genes were differentially expressed in FGS/kist kidney tissue compared to the control. Those genes were related to cell cycle/cell death, immune reaction, and lipid metabolism/vasculopathy, and the key molecules of their networks were TNF, IL-6/ 4, IFNγ, TP53, and PPARγ. Conclusion:This study confirmed that renal cell death, immune system activation with subsequent fibrosis, and lipid metabolism-related early vasculopathy were involved in the pathophysiology of FSGS. In addition, the relevance of methodology used in this study, namely transcriptome profiling, and Korean animal model of FGS/kist was validated. Further study would reveal novel pathophysiology of FSGS for new therapeutic targets.
참고문헌 (23)
- Eddy AA, "Nephrotic syndrome in childhood", Lancet, 362, pp.629~639 (2003)
- Savin VJ, "Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis", N Engl J Med, 334, pp.878~883 (1996)
- Hayden PS, "DNA expression analysis: serial analysis of gene expression, microarrays and kidney disease", Curr Opin Nephrol Hypertens, 12, pp.407~414 (2003)
- Yoshida T, "Global analysis of gene expression in renal ischemia-reperfusion in the mouse", Biochem Biophys Res Commun, 291, pp.787~794 (2002)
- Yoshida T, "Monitoring changes in gene expression in renal ischemia-reperfusion in the rat", Kidney Int, 61, pp.1646~1654 (2002)
- Alexander JJ, "Prominent renal expression of a murine leukemia retrovirus in experimental systemic lupus erythematosus", J Am Soc Nephrol, 13, pp.2869~2877 (2002)
- Hyun BH, "A new mouse strain manifesting high proteinuria and kidney glomerular defect", Lab Anim Sci, 41, pp.442~446 (1991)
- Lee CH, "Pathological Observation of FGS", NgaKist Mice with Glomerulosclerosis, 1996, pp.12, 51~59
- Oh HK, "Expression of Transforming Growth Factor-β and Morphologic Changes ofGlomerulosclerosisinFGS", NgaKist Mouse, 1998, pp.32, 35~42
- Ho-SunPark, "Pirfenidone Suppressed the Development of Glomerulosclerosis in the FGS", Kist mouse, 2003, pp.18(4), 527~533[DOI]
- 최영국, "Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney", GENE THERAPY, 10, pp.559~568, NATURE PUBLISHING GROUP
- Kim EH, "Quantitative trait loci for proteinuria in the focal glomerulosclerosis mouse model", Mamm Genome, 16, pp.242~250 (2005)
- Kim EH, "Quantitative trait Loci for glomerulosclerosis, kidney weight and body weight in the focal glomerulosclerosis mouse model", Exp Anim, 54, pp.319~325 (2005)
- Nishimura M, "Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder", J Exp Med, 179, pp.1053~1058 (1994)
- 한혜원, "Age-related differences in Adriamycin-induced nephropathy", Pediatric Nephrology, 19(7), pp.761~766, Springer Verlag
- Joy MS, "Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group", Clin J Am Soc Nephrol, 4, pp.39~47 (2009)
- Buckingham RE, "Peroxisome proliferator-activated receptor- gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats", Diabetes, 47, pp.1326~1334 (1998)
- Sarafidis PA, "Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis", Am J Kidney Dis, 55, pp.835~847 (2010)
- Motojima K, "Dual promoters and tissue-specific expression of rat transthyretin gene", Biochem Biophys Res Commun, 173, pp.323~330 (1990)
- Cohen AS, "The pathogenesis and biochemistry of amyloidosis", J Pathol, 151, pp.1~10 (1987)
- Tormey WP, "Clinical associations of an increased transthyretin band in routine serum and urine protein electrophoresis", Ann Clin Biochem, 30(Pt 6), pp.550~554 (1993)
- 한지환, "Antibody Status in Children with Steroid-Sensitive Nephrotic Syndrome", Yonsei Medical Journal, 51(2), pp.239~243 (2010), 연세대학교의과대학
- Schwab K, "Microarray analysis of focal segmental glomerulosclerosis", Am J Nephrol, 24, pp.438~447 (2004)